Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03159117
Title Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

melanoma

Therapies

PF-06688992

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.